Published in AIDS Weekly, May 10th, 2010
"So far, competitive inhibitors of the core particle gain most consideration as drugs. We...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.